Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 806.85 INR 14.7% Market Closed
Market Cap: 64.9B INR
Have any thoughts about
Supriya Lifescience Ltd?
Write Note

Intrinsic Value

The intrinsic value of one SUPRIYA stock under the Base Case scenario is 432.04 INR. Compared to the current market price of 806.85 INR, Supriya Lifescience Ltd is Overvalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SUPRIYA Intrinsic Value
432.04 INR
Overvaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Supriya Lifescience Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SUPRIYA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SUPRIYA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Supriya Lifescience Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Supriya Lifescience Ltd

Provide an overview of the primary business activities
of Supriya Lifescience Ltd.

What unique competitive advantages
does Supriya Lifescience Ltd hold over its rivals?

What risks and challenges
does Supriya Lifescience Ltd face in the near future?

Has there been any significant insider trading activity
in Supriya Lifescience Ltd recently?

Summarize the latest earnings call
of Supriya Lifescience Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Supriya Lifescience Ltd.

Provide P/S
for Supriya Lifescience Ltd.

Provide P/E
for Supriya Lifescience Ltd.

Provide P/OCF
for Supriya Lifescience Ltd.

Provide P/FCFE
for Supriya Lifescience Ltd.

Provide P/B
for Supriya Lifescience Ltd.

Provide EV/S
for Supriya Lifescience Ltd.

Provide EV/GP
for Supriya Lifescience Ltd.

Provide EV/EBITDA
for Supriya Lifescience Ltd.

Provide EV/EBIT
for Supriya Lifescience Ltd.

Provide EV/OCF
for Supriya Lifescience Ltd.

Provide EV/FCFF
for Supriya Lifescience Ltd.

Provide EV/IC
for Supriya Lifescience Ltd.

Show me price targets
for Supriya Lifescience Ltd made by professional analysts.

What are the Revenue projections
for Supriya Lifescience Ltd?

How accurate were the past Revenue estimates
for Supriya Lifescience Ltd?

What are the Net Income projections
for Supriya Lifescience Ltd?

How accurate were the past Net Income estimates
for Supriya Lifescience Ltd?

What are the EPS projections
for Supriya Lifescience Ltd?

How accurate were the past EPS estimates
for Supriya Lifescience Ltd?

What are the EBIT projections
for Supriya Lifescience Ltd?

How accurate were the past EBIT estimates
for Supriya Lifescience Ltd?

Compare the revenue forecasts
for Supriya Lifescience Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Supriya Lifescience Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Supriya Lifescience Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Supriya Lifescience Ltd compared to its peers.

Compare the P/E ratios
of Supriya Lifescience Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Supriya Lifescience Ltd with its peers.

Analyze the financial leverage
of Supriya Lifescience Ltd compared to its main competitors.

Show all profitability ratios
for Supriya Lifescience Ltd.

Provide ROE
for Supriya Lifescience Ltd.

Provide ROA
for Supriya Lifescience Ltd.

Provide ROIC
for Supriya Lifescience Ltd.

Provide ROCE
for Supriya Lifescience Ltd.

Provide Gross Margin
for Supriya Lifescience Ltd.

Provide Operating Margin
for Supriya Lifescience Ltd.

Provide Net Margin
for Supriya Lifescience Ltd.

Provide FCF Margin
for Supriya Lifescience Ltd.

Show all solvency ratios
for Supriya Lifescience Ltd.

Provide D/E Ratio
for Supriya Lifescience Ltd.

Provide D/A Ratio
for Supriya Lifescience Ltd.

Provide Interest Coverage Ratio
for Supriya Lifescience Ltd.

Provide Altman Z-Score Ratio
for Supriya Lifescience Ltd.

Provide Quick Ratio
for Supriya Lifescience Ltd.

Provide Current Ratio
for Supriya Lifescience Ltd.

Provide Cash Ratio
for Supriya Lifescience Ltd.

What is the historical Revenue growth
over the last 5 years for Supriya Lifescience Ltd?

What is the historical Net Income growth
over the last 5 years for Supriya Lifescience Ltd?

What is the current Free Cash Flow
of Supriya Lifescience Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Supriya Lifescience Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Supriya Lifescience Ltd

Current Assets 4.1B
Cash & Short-Term Investments 869.6m
Receivables 1.1B
Other Current Assets 2.2B
Non-Current Assets 6B
Long-Term Investments 724.9m
PP&E 5.2B
Intangibles 27m
Other Non-Current Assets 11.7m
Current Liabilities 754.4m
Accounts Payable 624.1m
Accrued Liabilities 3.8m
Other Current Liabilities 126.5m
Non-Current Liabilities 310.6m
Long-Term Debt 52.2m
Other Non-Current Liabilities 258.5m
Efficiency

Earnings Waterfall
Supriya Lifescience Ltd

Revenue
6.2B INR
Cost of Revenue
-2.1B INR
Gross Profit
4.2B INR
Operating Expenses
-2.1B INR
Operating Income
2.1B INR
Other Expenses
-494.7m INR
Net Income
1.6B INR

Free Cash Flow Analysis
Supriya Lifescience Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SUPRIYA Profitability Score
Profitability Due Diligence

Supriya Lifescience Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Exceptional 3-Year Average ROE
Positive Operating Income
65/100
Profitability
Score

Supriya Lifescience Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

SUPRIYA Solvency Score
Solvency Due Diligence

Supriya Lifescience Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Supriya Lifescience Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SUPRIYA Price Targets Summary
Supriya Lifescience Ltd

Wall Street analysts forecast SUPRIYA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUPRIYA is 581.4 INR with a low forecast of 500.96 INR and a high forecast of 676.2 INR.

Lowest
Price Target
500.96 INR
38% Downside
Average
Price Target
581.4 INR
28% Downside
Highest
Price Target
676.2 INR
16% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SUPRIYA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SUPRIYA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SUPRIYA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

64.9B INR

Dividend Yield

0.1%

Description

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics and Anti-Asthmatics. Its manufacturing facilities include delineated areas for quality check (QC); manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection.

Contact

MAHARASHTRA
Mumbai
Sonawala Road Goregoan, 207/208, Udyog Bhavan
+912240332727
supriyalifescience.com

IPO

2021-12-28

Employees

-

Officers

Founder, Executive Chairman & Whole Time Director
Dr. Satish Waman Wagh
Whole-time Director
Ms. Smita Satish Wagh
Managing Director
Dr. Saloni Satish Wagh
Joint Managing Director
Ms. Shivani Satish Wagh
Whole Time Director
Mr. Balasaheb Gulabrao Sawant
Chief Financial Officer
Mr. Krishna Raghunathan
Show More
Technical Head
Dr. Shireesh Bhalchandra Ambhaikar
Chief Scientific Officer
Dr. Sushanta Kumar Gouranga Mishra
Compliance Officer & Company Secretary
Ms. Shweta Shivdhari Singh
Head of Corporate Quality Assurance & Regulatory Affairs
Dr. Prashant Baban Zate
Show Less

See Also

Discover More
What is the Intrinsic Value of one SUPRIYA stock?

The intrinsic value of one SUPRIYA stock under the Base Case scenario is 432.04 INR.

Is SUPRIYA stock undervalued or overvalued?

Compared to the current market price of 806.85 INR, Supriya Lifescience Ltd is Overvalued by 46%.

Back to Top